UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
   Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934

          Date of Report (Date of earliest reported): February 23, 2006

                                  CARDIMA, INC.
               (Exact name of registrant as specified in charter)



       Delaware                         000-22419               94-3177883
(State or Other Jurisdiction of   (Commission File Number)   (IRS Employer
 Incorporation or Organization)                              Identification No.)

                47266 Benicia Street, Fremont, California, 94538
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (510) 354-0300

                                   Copies to:
                            Richard A. Friedman, Esq.
                       Sichenzia Ross Friedman Ference LLP
                           1065 Avenue of the Americas
                            New York, New York 10018
                              Phone: (212) 930-9700
                               Fax: (212) 930-9725

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))



Section 5 - Corporate Governance and Management
Item 5.02 Election of Directors

On February 23, 2006,  Tina Sim, Tony Shum and Robert  Cheney were  appointed to
the Board of Directors of Cardima, Inc. (the "Company").

Tina Sim

Ms. Sim is a  Chartered  Accountant  and a CFA Charter  holder.  From 1992 until
1995, Ms. Sim worked for Deloitte & Touche in Canada. From 1997 to 1999, Ms. Sim
worked for Deloitte Touche Tohmatsu in Hong Kong. Ms. Sim's background  includes
advisory work on general accounting, tax and regulatory matters and cross-border
jurisdictional issues. Ms. Sim is currently semiretired.

Tony Shum

Mr. Shum is a Business Development  executive for the global banking group HSBC.
Mr.  Shum is a  Chartered  Accountant  and has worked  for  Deloitte & Touche in
Canada and Price Waterhouse in Hong Kong. Upon leaving public practice, Mr. Shum
joined Walt Disney  Television  International  where he helped to establish  its
broadcast television business in the Asia-Pacific region. He has also worked for
a private  equity  venture  capital  investment  firm and has provided  business
strategy and analysis services in Asia Pacific and Europe for businesses ranging
from start-up ventures to multi-national corporations.

Robert Cheney

Mr. Cheney is a corporate  consultant  based in Hong Kong.  Mr. Cheney is also a
director and shareholder of Apix International Limited ("Apix" or the "Lender").
Mr.  Cheney  was   previously  the  Chairman  and  CEO  of  a  Hong  Kong  based
telecommunications  and Internet Services Company.  Prior to his business career
Mr. Cheney was a corporate  lawyer in private  practice  qualified in Hong Kong,
Canada and Britain.

During the past two years,  Cardima was a party to the following  transaction in
which Robert Cheney has a material interest. As previously disclosed,  on August
26,  2005,  Cardima  entered  into a  $3,000,000  secured  Loan  Agreement  (the
"Original Loan Agreement") with Apix International Limited, which has been fully
funded. Also as previously disclosed, on February 14, 2006, Cardima entered into
a loan facility term sheet (the "New Loan  Facility")  with Apix which  provides
for the roll-over of the Original Loan  Agreement and the grant of an additional
loan  facility in the amount of  $660,000 at an interest  rate of 10% per annum.
$200,000  was advanced to Cardima  upon  signing of the New Loan  Facility  term
sheet (the "First Draw Down"). The additional $460,000 of funding is expected to
be funded as follows:

o $220,000.00  on or after March 3, 2006 subject to an amended  loan  agreement
being executed in accordance with the terms of the term sheet and subject to the
sole and absolute discretion of the Lender (the "Second Draw Down");

o $240,000  on or after  March  22,  2006,  subject  to the  sole and  absolute
discretion of the Lender (the "Third Draw Down").

In addition, the Company and the Lender have agreed to the following terms:

o New Maturity Date. The maturity date of the Original Loan Facility is extended
from February 28, 2006 to May 18, 2006.

o New  Warrants  and Price  Adjustment  to  Existing  Warrant.  Pursuant  to the
Original Loan  Facility,  the Company issued a warrant to the Lender to purchase
30,000,000  shares of the Company's  common stock at an exercise  price of $0.10
per share (the  "Original  Warrant").  Pursuant  to the New Loan  Facility,  the
exercise price of the Original  Warrant has been adjusted to $0.06 per share. In
addition,  the  Company  has  granted  the  Lender  a new  warrant  to  purchase
23,800,000  shares of the Company's  common stock at an exercise  price of $0.06
per share for a term of ten years.  In addition,  upon  completion of the Second
and Third Draw Downs,  the Company will grant the Lender warrants to purchase an
additional  8,000,000  shares of the Company's common stock at an exercise price
of $0.06 per share for a term of ten years.


                                       2


o Conversion Rights. The Company has granted the Lender the right to convert the
loan  principal,  interest,  facility  fees and exit  fees  into  shares  of the
Company's common stock at a conversion price of $0.06 per share.

o Fee  Adjustment.  The facility fee has been increased from $60,000 to $80,000.
In addition, the exit fee has been increased from $900,000 to $1,300,000.

o New Exit  Fees.  Upon  completion  of the First  Draw  Down,  the exit fee was
increased by $80,000.  In addition,  the exit fee will increase by $180,000 upon
completion of the Second and Third Draw Downs.

o Registration Rights.  Pursuant to the New Loan Facility, the Company agrees to
register the shares  underlying the loan principal,  facility fees, and warrants
on a registration statement on Form S-1 as soon as practicable after the date of
issuing the warrant, but in any event no later May 31, 2006.

The issuance of the securities  underlying the New Loan Facility are exempt from
registration  requirements of the Securities Act of 1933 (the "Securities  Act")
pursuant to Section 4(2) of such Securities Act and/or  Regulation D promulgated
thereunder  based  upon  the  representations  of  the  Lender  that  it  is  an
"accredited investor" (as defined under Rule 501 of Regulation D) and that it is
purchasing such  securities  without a present view toward a distribution of the
securities.  In  addition,  there  was no  general  advertisement  conducted  in
connection with the sale of the securities.


                                       3


Item 9.01 Financial Statements and Exhibits.

(a) Financial statements of business acquired.

Not applicable.

(b) Pro forma financial information.

Not applicable.

(c) Exhibits.

Exhibit
Number    Description

10.1    Loan Agreement  dated August 28, 2005 by and between Apix  International
        Limited and Cardima, Inc. (as incorporated by reference to the Company's
        Form 8-K filed with the Securities and Exchange  Commission on September
        1, 2005).

10.2    10%  Promissory  Note  of  Cardima,  Inc.  dated  August  26,  2005  (as
        incorporated  by  reference  to the  Company's  Form 8-K filed  with the
        Securities and Exchange Commission on September 1, 2005).

10.3    Warrant  Agreement  to purchase  shares of the common  stock of Cardima,
        Inc.  dated as of August 28, 2005 (as  incorporated  by reference to the
        Company's Form 8-K filed with the Securities and Exchange  Commission on
        September 1, 2005).

10.4    Security  Agreement dated August 12, 2005, by and between Cardima,  Inc.
        and Apix  International  Limited (as  incorporated  by  reference to the
        Company's Form 8-K filed with the Securities and Exchange  Commission on
        August 16, 2005).

10.5    Trademark  Security  Agreement  dated  August 12,  2005,  by and between
        Cardima,  Inc.  and  Apix  International  Limited  (as  incorporated  by
        reference  to the  Company's  Form 8-K  filed  with the  Securities  and
        Exchange Commission on August 16, 2005).

10.6    Patent Security Agreement dated August 12, 2005, by and between Cardima,
        Inc. and Apix International Limited (as incorporated by reference to the
        Company's Form 8-K filed with the Securities and Exchange  Commission on
        August 16, 2005).

10.7    Patent,  Trademark and  Copyright  Security  Agreement  dated August 12,
        2005, by and between Cardima,  Inc. and Apix  International  Limited (as
        incorporated  by  reference  to the  Company's  Form 8-K filed  with the
        Securities and Exchange Commission on August 16, 2005).

10.8    Loan Facility Term Sheet (as incorporated by reference to Cardima's Form
        8-K filed with the  Securities  and Exchange  Commission on February 21,
        2006)


                                       4


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                  CARDIMA, INC.



Date: March 1, 2006               By: /s/ Gabriel B. Vegh
                                      -------------------
                                  Name:   Gabriel B. Vegh
                                  Chief Executive Officer,
                                  Chief Financial Officer



                                       5